Stockhead’s Road to 2025 video series highlights companies’ key 2024 achievements and the routes they’re plotting towards a successful year ahead.

In this episode, Sarah Hughan covers BlinkLab (ASX:BB1) whose software as a medical device, produces products that use computer vision and advanced machine learning models.

It’s been a big year for BlinkLab since its IPO in April, as it continues to develop digital diagnostic tools for autism, ADHD and other mental conditions. 

Tune in to find out what to look out for in the new year.

 

This video was developed in collaboration with BlinkLab a Stockhead advertiser at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.

Read MoreHealthMedtech

Featured Companies

You might be interested in